These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20460922)

  • 1. The effect of lifestyle changes in non-alcoholic fatty liver disease.
    Centis E; Marzocchi R; Di Domizio S; Ciaravella MF; Marchesini G
    Dig Dis; 2010; 28(1):267-73. PubMed ID: 20460922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach.
    Bellentani S; Dalle Grave R; Suppini A; Marchesini G;
    Hepatology; 2008 Feb; 47(2):746-54. PubMed ID: 18098321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G; Gambino R; Cassader M
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
    Bugianesi E; Marzocchi R; Villanova N; Marchesini G
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1105-16. PubMed ID: 15561641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of nonalcoholic fatty liver disease: current status.
    Duvnjak M; Tomasic V; Gomercic M; Smircic Duvnjak L; Barsic N; Lerotic I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():57-66. PubMed ID: 20388946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: the potential role of nutritional management.
    Leclercq IA; Horsmans Y
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):766-73. PubMed ID: 18827582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-alcoholic fatty liver].
    Tagle Arrospide M
    Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.